Researchers of the LKS Faculty of Medicine have access to world-class research facilities and technology to support them in their scholarly pursuits.
State-of-the-art BSL-3 laboratories and animal facilities are available for researchers to conduct microbiological, virological and epidemiological studies.
The Centre for Comparative Medicine Research (CCMR) is an AAALAC International accredited service centre responsible for the breeding of specific pathogen free laboratory animals for research and teaching, and promotion of humane care and responsible usage of laboratory animals in the university.
The Centre for PanorOmic Sciences (CPOS) was established to further strengthen the provision and development of cutting-edge technological platforms and support/services for researchers. It also reinforces research and training components to complement the surge in multi-omics big data.
The University of Hong Kong Clinical Trials Centre (HKU-CTC) is an academic clinical research organization authorized as the central platform for management and coordination of clinical studies under HKU and its affiliated teaching hospital – Queen Mary Hospital.
The Biostatistics and Clinical Research Methodology Unit supports the Faculty's research activities in by providing expert advice on biostatistics and clinical research methodology. The Unit also provides statistical consultancy to public bodies and private companies.
The Faculty currently has four State Key Laboratories (SKLs) recognised by the Ministry of Science and Technology, which are partnered with and work closely alongside SKLs in Mainland China.
The School of Public Health has been designated as a WHO Collaborating Centre for Infectious Disease Epidemiology and Control. The designation of HKU School of Public Health as a WHO CC is the first of such kind at the University.
The Centre of Influenza Research at HKU is one of 12 laboratories worldwide designated as a WHO H5 reference laboratory. Its mandate is to provide international reference laboratory services and training on H5 and other animal influenza viruses with zoonotic potential, to provide WHO with data and risk assessment relevant to such zoonotic threats and advice on selection of relevant viruses for pre-pandemic vaccine development. Learn more: www.who.int/influenza/gisrs_laboratory/h5_reflabs/en/